Detalhe da pesquisa
1.
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases.
J Intern Med
; 293(5): 648-655, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36843323
2.
Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases.
Rheumatology (Oxford)
; 2023 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37773994
3.
Therapeutic drug monitoring in inflammatory bowel disease: implementation, utilization, and barriers in clinical practice in Scandinavia.
Scand J Gastroenterol
; 58(1): 25-33, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35996928
4.
Humoral immune response to SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive medication: association to serum drug levels and disease type.
Scand J Gastroenterol
; 58(8): 874-882, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788656
5.
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study.
BMC Med
; 20(1): 378, 2022 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36199139
6.
Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial.
J Intern Med
; 292(3): 477-491, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35411981
7.
Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia.
Eur Heart J
; 42(39): 4064-4072, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34405870
8.
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
JAMA
; 326(23): 2375-2384, 2021 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932077
9.
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
JAMA
; 325(17): 1744-1754, 2021 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33944876
10.
The effect of infliximab in patients with chronic low back pain and Modic changes (the BackToBasic study): study protocol of a randomized, double blind, placebo-controlled, multicenter trial.
BMC Musculoskelet Disord
; 21(1): 698, 2020 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087100
11.
Biosimilar drugs just as good, and much cheaper. / Biotilsvarende legemidler like gode, mye billigere.
Tidsskr Nor Laegeforen
; 139(6)2019 Mar 26.
Artigo
em Norueguês
| MEDLINE | ID: mdl-30917643
12.
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials.
Lancet Rheumatol
; 6(4): e226-e236, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402891
13.
Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study.
Front Immunol
; 15: 1296273, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38455062
14.
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study.
RMD Open
; 10(2)2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38599653
15.
Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients.
EBioMedicine
; 97: 104833, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37844534
16.
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study.
Lancet Rheumatol
; 5(1): e36-e46, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36415604
17.
Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine.
BioDrugs
; 36(6): 731-748, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315391
18.
Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study.
Lancet Rheumatol
; 4(3): e177-e187, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34977602
19.
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy.
RMD Open
; 8(2)2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328399
20.
Serum etanercept concentrations in relation to disease activity and treatment response assessed by ultrasound, biomarkers and clinical disease activity scores: results from a prospective observational study of patients with rheumatoid arthritis.
RMD Open
; 7(3)2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34911811